Luxiq Drug Patent Profile
✉ Email this page to a colleague
When do Luxiq patents expire, and what generic alternatives are available?
Luxiq is a drug marketed by Mylan and is included in one NDA.
The generic ingredient in LUXIQ is betamethasone valerate. There are sixty-six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Luxiq
A generic version of Luxiq was approved as betamethasone valerate by FOUGERA PHARMS INC on August 31st, 1983.
Summary for Luxiq
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 64 |
Patent Applications: | 5,095 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for Luxiq |
What excipients (inactive ingredients) are in Luxiq? | Luxiq excipients list |
DailyMed Link: | Luxiq at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for Luxiq
Paragraph IV (Patent) Challenges for LUXIQ
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
LUXIQ | Foam | betamethasone valerate | 0.12% | 020934 | 1 | 2007-08-10 |
US Patents and Regulatory Information for Luxiq
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan | LUXIQ | betamethasone valerate | AEROSOL, FOAM;TOPICAL | 020934-001 | Feb 28, 1999 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Luxiq
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mylan | LUXIQ | betamethasone valerate | AEROSOL, FOAM;TOPICAL | 020934-001 | Feb 28, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Mylan | LUXIQ | betamethasone valerate | AEROSOL, FOAM;TOPICAL | 020934-001 | Feb 28, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Luxiq
See the table below for patents covering Luxiq around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Portugal | 813413 | ⤷ Try a Trial | |
Austria | 253367 | ⤷ Try a Trial | |
European Patent Office | 0813413 | MOUSSE CONTENANT UN CORTICOSTEROIDE (CORTICOSTEROID-CONTAINING FOAM) | ⤷ Try a Trial |
New Zealand | 302727 | FOAMABLE CORTICOSTEROID COMPOSITION | ⤷ Try a Trial |
Hungary | 228890 | CORTICOSTEROID-CONTAINING FOAM AND USE THEREOF | ⤷ Try a Trial |
Slovakia | 119097 | CORTICOSTEROID-CONTAINING PHARMACEUTICAL COMPOSITION | ⤷ Try a Trial |
Canada | 2214436 | COMPOSITION PHARMACEUTIQUE CONTENANT UN CORTICOSTEROIDE (CORTICOSTEROID-CONTAINING PHARMACEUTICAL COMPOSITION) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |